Notably, in patients with non-small-cell lung cancer (NSCLC), it was demonstrated that high expression of VEGF in TAMs promotes angiogenesis and associates with poorer prognosis [57]. The gene discussed is VEGFA; the disease is non-small cell lung carcinoma.